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Introduction
Neuroendocrine carcinoma accounts for less than 5% of
cancers of unknown primary site. When primary pancrea-
tic cancer is diagnosed, 95% of cases are classified as
aggressive adenocarcinoma and the remaining 5% of cases
are caused by indolent behaving neuroendocrine carci-
noma. We present a rare case of well-differentiated
neuroendocrine carcinoma of the pancreas extending to
the transverse colon, small bowel, stomach, and lymph
nodes with metastasis to the caudate lobe of the liver. The
patient had a two-year history of midepigastric abdominal
pain that eventually sent him to the Emergency Depart-
ment and after extensive tests we removed the entire tumor
with margins free of growth. Included in this case report
are many illustrations to show the severity and we further
emphasize the importance of examining patients thor-
oughly especially when vague symptoms are chronic.
Case presentation
A 58-year-old African American male presented to the
Emergency Department by ambulance complaining of a
constant, sharp, and worsening midepigastric pain that
radiated posterior for approximately 30 minutes. The pain
was perceived to be 10 out of 10 and was described as an
inflated balloon that was squeezing from the inside out.
The paramedics found the patient in his house hypoten-
sive and lying in a right lateral decubitus position. The
patient was given a bolus of normal saline and his blood
pressure responded appropriately. Upon examination, the
patient claimed to of had a two-year history of worsening
mild midepigastric and left upper quadrant abdominal
pain and was seen by his primary care provider whom
prescribed him a proton pump inhibitor (PPI) which
partially relieved some symptoms. In addition, the patient
complained of being nauseated, feeling bloated after
meals, having a history of bloody stools one week prior
to admission, and increased pain after eating. He denied
vomiting or early satiety. Vital signs on admission were
stable.
Past medical history included gastroesophageal reflux
disease (GERD), hyperlipidemia and impaired fasting
glucose. His medications consisted of a PPI, H2-blocker
and simvastatin. The only past surgical history was an
appendectomy. The patient was a truck driver for several
years. He denied alcohol, drug use, and smoked approxi-
mately ½ packs of cigarettes a day for the past 40 years. He
reported his two nieces having an unspecified type of
cancer but no other known family history of cancer or
heart diseases. Review of systems was negative except for
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patient denied weight loss, fatigue, fever, shortness of
breath, and/or chest pain. On physical examination, the
abdomen was hard, guarding was noted, and there was
direct and rebound tenderness noted in all four quadrants
but worse in the epigastric area.
On admission, the patient had a complete laboratory
workup involving all systems. The abnormalities found
mildly decreased were hemoglobin of 12.9 g/dl, hematocrit
of 39.6%, albumin of 3.1 g/dl, and sodium of 132 mEq/l.
The only abnormalities found mildly increased was the
red blood distribution width of 16%, white blood cell
count of 15,100 ul, corrected calcium of 11.32 mg/dl,
glucose of 129 mg/dl, prothrombin time of 12.2 seconds,
and the international ratio of 1.2 seconds. Stool guaiac
was negative.
Computed tomography (CT) of the abdomen and pelvis
on admission revealed a large 4.7 centimeter (cm)
lobulated hypodense mass in the region of the porta
hepatis probably arising from the liver with the possibility
of adjacent morphologic tubular lymph nodes or satellite
lesions (Figure 1). Extending from the lobulated mass of
the liver was a broad lobulated 10 cm band of density just
deep to the rectus muscle extending from the upper
abdomen to the level below the iliac crest, which possibly
represented extraperitoneal infiltration. Additionally, an
enhancing lesion was seen in the caudate lobe of the liver
that was most likely metastasis. Blood was noted in both
paracolic gutters, and there was a pancake-type density
along the anterior abdominal wall, which was most likely
blood that extended into the right pelvis representing
omental caking. After review of the CT, serum measure-
ments of Cancer antigen (CA) 19-9, Carcino embryonic
antigen (CEA), and Alpha-fetoprotein (AFP)were found to
be within normal limits. Serum Helicobacter pylori was
positive. Colonoscopy and esophagastroduodenoscopy
was recommended after review of the CT and findings
were mild antral gastritis and a nearly obstructing mass in
the descending colon. Recommendations were to rule out
other malignancies and surgical intervention. An acute
abdomen series with chest radiograph was consistent with
the CT with additional findings of patchy and streaky
infiltrate of the right and left lung bases and question of
the mass in the left upper quadrant displacing the stomach
medially. There was no evidence of acute obstruction or air
under the diaphragm. Positron emission tomography scan
was performed to evaluate for metastases and results
showed increase uptake in the left upper quadrant, and
about 4 cm of caudate lobe of the liver.
Utilizing CT guidance, biopsy of the large mass in the left
upper quadrant was performed by Interventional Radi-
ology on the same day of admission. Pathology results two
days later showed a well-differentiated neuroendocrine
carcinoma. The architecture revealed insular and trabecu-
lar morphologies, and the Ki-67 index was approximately
30% positive (Figure 2). Microscopic sections showed
nested epithelial cells with moderately increased mitotic
activity, nuclear atypia, irregular nuclear contours and
hyperchromasia. Immunohistological stains were
Figure 1. Computed tomography (CT) of the abdomen
and pelvis. A large 4.7 centimeter (cm) lobulated hypodense
mass is shown in the region of the porta hepatis likely
secondary to the tumor mass.
Figure 2. Histological demonstration of the well-
differentiated neuroendocrine carcinoma. Pathology slides
from the tumourus mass showing a well-differentiated
neuroendocrine carcinoma. The architecture is consistent
with the insular and trabecular morphologies, and the
Ki-67 index is approximately 30% positive.
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component was positive for cytokeratin AE1/AE3, neu-
roendocrine marker synaptophysin was positive, neuroen-
docrine marker chromogranin-A was positive,
neuroendocrine marker neurone specific enolase was
positive, and CA 19-9 was negative.
On hospital day number six the surgery service performed
a diagnostic laparoscopy, exploratory laparotomy with
distal pancreatectomy, splenectomy, partial gastrectomy,
left colectomy, and resection of the caudate lobe of the
liver (Figure 3). Pre and postoperative diagnoses were
well-differentiated neuroendocrine tumor of the pancrea-
tic tail with metastasis to the caudate lobe of the liver. After
diagnostic laparoscopy revealed a moderate amount of
blood around the peritoneal cavity and metastasis to the
liver it was necessary to convert to exploratory laparotomy.
Blood was aspirated from theabdominal cavity andsentto
cytology, which later revealed numerous neutrophils
admixed with red blood cells yet no malignant cells.
General inspection of the peritoneal cavity revealed a
tumor in the caudate lobe as well as a large 10 cm mass
that was fixed in the left upper quadrant. The tumor itself
was quite vascular and was surrounded by varices, which
was most likely the cause for the blood throughout the
abdomen as well as within the lesser sac. Additionally, a
periaortic lymph node appeared grossly positive and was
then dissected and sent for analysis. There was no evidence
of metastases in the pelvis, small bowel, or omentum. The
diaphragm was not involved or infiltrated by the tumor
and neither was the left kidney or adrenal glands.
Overall, the surgery was successful. At the end of the
procedure two 10 ml Jackson-Pratt drains were inserted
into the lesser sac and left upper quadrant.
Gross specimens were sent to pathology in three parts:
frozen section of the periaortic lymph node measured 1.0
by 0.8 by 0.4 cm, the caudate lobe of the liver measured
4.0 by 3.5 by 2.5 cm, and the massive left upper quadrant
tumor that consisted of an en bloc resection of the spleen,
partial transverse colon, partial small bowel, pancreatic
tail, partial distal stomach, adipose tissue, and lymph
nodes. The spleen measured 12 by 7.5 by 2.5 cm, the colon
measured 33 cm in length and 4 cm in diameter, the
pancreatic tail measured 12 by 8 by 6 cm, a portion of the
small bowel measured 15 cm in length and about 3 cm in
diameter, and a small portion of the distal stomach
measured 9 by 6.5 cm (Figure 4). The massive tumor
invaded into the serosa of the transverse colon, distal
stomach, and small bowel. The tumor appeared to
compress the capsule of the spleen, however, no direct
invasion was identified (Figure 5). After sectioning of all
the involved organs it was noted that the tumor originated
Figure 3. Exploratory laparotomy. Distal pancreatectomy,
splenectomy, partial gastrectomy, left colectomy, and
resection of the caudate lobe of the liver were
performed during the surgical procedure.
Figure 4. Gross specimen of the liver. One of the specimens
removed from the body are shown here which presents the
caudate lobe of the liver measured 4.0 by 3.5 by 2.5 cm.
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multiple lymph nodes ranging in size from 0.3 to 1.0 cm
were analyzed.
Microscopic sections were analyzed and found the
perioarotic lymph node to be negative for metastatic
carcinoma. Microscopic sections of the caudate lobe of the
liver showed metastatic well-differentiated neuroendo-
crine carcinoma (Figures 6 and 7). Sections of the massive
left upper quadrant mass showed invasive well-differen-
tiated neuroendocrine carcinoma characterized by cells
with high nuclear to cytoplasmic ratio, irregular nuclear
contours and hyperchromasia arranged in trabecular and
insular patterns. There were 21 of 21 lymph nodes positive
for metastatic carcinoma. Margins of resection were free
of tumor. Tumor node metastasis (TNM) staging was
T4, N1, M1.
Overall, the patient tolerated the procedure and hospital
stay well. During thecourse of hospitalization his painwas
well controlled with morphine, and his glucose was well
controlled after being weaned off of an insulin drip and
placed on a sliding scale. Vaccinations for encapsulated
organisms including pneumococcal, Streptococcus pneumo-
niae, Haemophilus influenza and Neisseria meningitides were
administered. Twenty days post-admission the patient was
discharged from the hospital with instructions not to lift
more than 15 pounds, and to follow-up with surgery in
one week.
Discussion
When the initial work-up, including physical examination,
laboratory and radiographic studies fails to identify the
primary site of a tumor with symptoms of referable to a
metastatic site, light microscopic evaluation of biopsy
material is necessary. Cancer of unknown primary site is a
common entity and based on five histological categories:
adenocarcinoma, poorly-differentiated carcinoma, poorly-
differentiated neoplasm, squamous cell carcinoma, and
neuroendocrine carcinoma [1]. Neuroendocrine carci-
noma accounts for less than 5% of cancers of unknown
primary site [2]. With that in mind, we present the clinical,
pathological, histological and diagnostic features of well-
differentiated neuroendocrine carcinoma which emphasis
placed on pancreatic neuroendocrine tumors as seen in
this case report.
Neuroendocrine carcinomas falls into three broad cate-
gories: poorly, moderately and well-differentiated
Figure 5. Splenic tissue. This histological picture is showing
the tumor compressing the capsule of the spleen without
any direct invasion.
Figures 6 & 7. Microscopic sections of the caudate lobe of
the liver. These pictures are demonstrating metastatic
well-differentiated neuroendocrine carcinoma in different
magnifications (exact numbers are mentioned in the figures).
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endocrine carcinomas usually have a high grade malig-
nancy and are characteristically small cell undifferentiated
or morphologically anaplastic by light microscopy [3].
Moderately-differentiated neuroendocrine carcinomas,
such as atypical carcinoid tumors, manifest cellular pleo-
morphism, nuclear atypia, frequent mitosis, and necrosis
[4]. In contrast, well-differentiated neuroendocrine carci-
nomas have variable and most often indolent biologic
behaviors [5]. Histologically, well-differentiated neuro-
endocrine carcinomas show uniform and small cells
organized in organoid or trabecular architecture [6].
Subtypes of well-differentiated neuroendocrine carcino-
mas include typical carcinoid tumors, pancreatic islet cell
(neuroendocrine) tumors, paragangliomas, pheochromo-
cytomas, and medullary thyroid carcinomas [5].
With well-differentiated neuroendocrine carcinomas
encompassing such a broad spectrum of neoplasms it is
pertinent to further classify them depending on whether
they have a neural or an epithelial origin. Paragangliomas
are of neural origin and the epithelial group can be
subdivided into the remaining types of neuroendocrine
carcinomas [7]. In our case, the epithelial component was
illustrated microscopically by areas of nested and trabe-
cular (neuroendocrine) growth, large cell size, irregular
nuclear contours, and coarse nuclear chromatin. In
addition, the immunohistochemical documentation
showed immunoreactivity for markers of epithelial and
neuroendocrine differentiation with positivity for cytoker-
atin AE1/AE3, synaptophysin, chromogranin, and neurone
specific enolase [8]. Recognition of this unusual morpho-
logic appearance is of importance to avoid mistaking these
lesions for other types of malignant neoplasms.
The majority of well-differentiated neuroendocrine carci-
nomas involve the gastrointestinal tract, and therefore are
referred to as gastroenteropancreatic neuroendocrine
carcinomas, however neuroendocrine carcinomas have
been found to occur in almost every organ in the body [9].
Gastroenteropancreatic neuroendocrine tumors are rela-
tively rare, and pancreatic endocrine tumors are even more
rare [10]. In our case the tumor originated in the pancreas
and further infiltrated the transverse colon, small bowl,
stomach, and lymph nodes within the adipose tissue.
Literature review reported that low-grade neuroendocrine
carcinomas, such as metastatic carcinoid or pancreatic
endocrine tumors, are occasionally found at metastatic
sites without an obvious primary site but almost always
involve the liver [11]. Following the literature, in this case
of pancreatic neuroendocrine origin there was metastasis
specific to the caudate lobe of the liver.
Pancreatic endocrine tumors or islet cell tumors may be
nonfunctional or functional depending on whether or not
the tumor was secreting excessive amounts bioactive
substances such as insulin, gastrin, somatostatin, vasoac-
tive intestinal peptide, or glucagon and further causing
associated symptoms [12]. Initially the patient presented
with hypercalcemia, impaired fasting glucose, and GERD
but due to urgency to undergo surgery and expected delay
of the pathology it was not evident to look into these
conditions until after the surgery. Therefore, we recom-
mend looking into abnormal laboratory values or diseases
before surgery to evaluate for associations related to
neuroendocrine syndromes. In this case we cannot be
certain if the patient was suffering from functional or
nonfunctional well-differentiated neuroendocrine carci-
noma of the pancreas. Since part of the stomach was
removed it was difficult to determine if the GERD that the
patient was suffering from preoperatively was due to high
gastrin levels and/or if the tumor infiltration pushing
upwards on the stomach was causing the acid reflux
symptoms. In addition, it was difficult to determine
postoperatively if the hypercalcemia, renal stone and/or
the impaired glucose fasting levels as seen in our patient
were attributed to a functional versus nonfunctional
pancreatic endocrine tumor.
We looked into reasons of why metastasis occurred in the
caudate lobe of the liver and not the other three lobes.
Interesting, the caudate lobe is the only part of the liver
that has hepatic venous drainage encompassing a few
sizeable and several smaller branches that flow directly
into the inferior vena cava [13]. Whether or not that is
relevant it was interesting because even though many
studies have reported tumors frequently infiltrating the
parenchyma of the caudate lobe and/or its bile ducts it is
still a rare entity [14,15].
Although there is abundant literature on neuroendocrine
carcinomas [5,7,9], to our knowledge, there has not been a
case presentation of neuroendocrine carcinoma evolving
from the pancreas with metastasis to the caudate lobe of
liver of such massive size. We have included many
illustrations to show the severity of this case and to
emphasize the importance of examining patients thor-
oughly especially when vague symptoms are chronic.
When primary pancreatic cancer is diagnosed, 95% of
cases are adenocarcinoma in origin and the remaining 5%
are due to neuroendocrine carcinoma [16]. In contrast to
neuroendocrine carcinomas, adenopancreatic cancers are
generally very aggressive [17]. A study assessed the clinical
relevance of the World Health Organization and TNM
classifications in patients with pancreatic neuroendocrine
carcinomas and found that the five-year survival rate to be
44% [18]. Another study found the five-year survival rate
to be 58.3% and concluded that patients with well to
moderately differentiated tumors had a better (63.9%)
five-year prognosis than those with poorly differentiated
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five-year survival rate to be 80% for aggressive surgical
resection for pancreatic neuroendocrine tumors [20].
Regardless of the survival rate, the prognosis seems to be
determined by various biological factors. With regard to
the principles of surgical oncology, tumor-free resection
margins are fundamental and radical surgical procedures
are justified in selected patients.
Conclusions
Well-differentiated neuroendocrine carcinomas have vari-
able and most often indolent biologic behaviors, and
microscopically show uniform and small cells organized
in organoid or trabecular architecture. Biopsy and immu-
nohistology is necessary to distinguish the various types of
neuroendocrine carcinomas whether they are epithelial
versus neural origin or poor versus well-differentiated and
additional laboratory workup should be done to differ-
entiate between functional and nonfunctional types of
pancreatic endocrine tumors which may be associated
with neuroendocrine syndromes. More importantly, neu-
roendocrine carcinomas of all kind have been capable of
local recurrence and distant metastasis, and therefore,
close clinical correlation and appropriate treatment are
important factors attributed to improving the overall
survival rate.
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